CoChat

Severe Diabetes Associated with Protease Inhibitor Therapy

Visnegarwala, Fehmida, Krause, Kurt L., Musher, Daniel M. · 1997 · Annals of Internal Medicine
Cited by 136

The DOI matches its Crossref record.

Abstract

Letters15 November 1997Severe Diabetes Associated with Protease Inhibitor TherapyFehmida Visnegarwala, MD, Kurt L. Krause, MD, PhD, and Daniel M. Musher, MDFehmida Visnegarwala, MDVeterans Affairs Medical Center; Houston, TX 77030-4211, Kurt L. Krause, MD, PhDVeterans Affairs Medical Center; Houston, TX 77030-4211, and Daniel M. Musher, MDVeterans Affairs Medical Center; Houston, TX 77030-4211Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-127-10-199711150-00016 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:Protease inhibitors block the action of aspartate protease, which is required to produce new virions. We describe a patient in whom symptomatic hyperglycemia was associated with the protease inhibitor nelfinavir, perhaps as a result of inhibition of the protease that converts proinsulin to insulin.A 46-year-old man with advanced-stage AIDS was receiving didanosine and lamuvidine. His viral load was 380 000 RNA copies/mL, and his CD4+ count was 20 cells/mm3. Treatment was changed to nelfinavir, zidovudine, and lamivudine. Other medications were trimethoprim-sulfamethoxazole, ciprofloxacin, clarithromycin, ethambutol, itraconazole, megestrol acetate, phenytoin, amitryptyline, and carbamazepine. The patient's mother had type ...References1. Henry K, Rathgaber S, Sullivan C, McCabe K. Diabetes mellitus induced by megestrol acetate in a patient with AIDS and cachexia. Ann Intern Med. 1992; 116:53-4. Google Scholar2. Murray M, Lumpkin MD. FDA Public Health Advisory: Reports of Diabetes and Hyperglycemia in Patients Receiving Protease Inhibitors for the Treatment of Human Immunodeficiency Virus (HIV). Bethesda, MD: Food and Drug Administration: 1997. Google Scholar3. Tezapsidis N, Noctor S, Kannan R, Krieger TJ, Mende-Mueller L, Hook VY. Stimulation of "Prohormone Thiol Protease" (PTP) and [Met] encephalin by forskolin. J Biol Chem. 1995; 270:13285-90. Google Scholar4. O'Rahilly S, Gray H, Humphreys PJ, Krook A, Polonsky KS, White A, et al. Impaired processing of prohormones associated with abnormalities of glucose homeostasis and adrenal function. N Engl J Med. 1996; 333:1386-90. Google Scholar5. Cawley NX, Pu LP, Loh YP. Immunological identification and localization of yeast aspartic protease 3-like prohormone-processing enzymes in mammalian brain and pituitary. Endocrinology. 1996; 137:5135-43. Google Scholar Author, Article, and Disclosure InformationAffiliations: Veterans Affairs Medical Center; Houston, TX 77030-4211 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByDiabetes and HIVReversible diabetes mellitus induced by use of, and improved after discontinuation of, the antiretroviral medication zidovudine: a case reportFirst case of pancreas transplant alone in a patient with diabetes and HIV infectionImpaired glucose metabolism in HIV-infected pregnant women: a retrospective analysisNew-Onset Diabetes and Antiretroviral Treatments in HIV-Infected Adults in ThailandInfections virales et diabète en AfriqueMetabolic Abnormalities in HIV-Infected Populations without or with Antiretroviral Therapy (ART)A Randomized Controlled Trial to Assess Safety, Tolerability, and Antepartum Viral Load with Increased Lopinavir/Ritonavir Dosage in PregnancyHIV and diabetesNutrition and the HIV-associated lipodystrophy syndromeThe Burden of Diabetes and Hyperlipidemia in Treated HIV Infection and Approaches for Cardiometabolic CareAntiretroviral use during pregnancy for treatment or prophylaxisIssues of Prematurity and HIV InfectionPediatric antiretroviral therapyBoosting Dose Ritonavir Does Not Alter Peripheral Insulin Sensitivity in Healthy HIV-Seronegative VolunteersPremature onset of cardiovascular disease in HIV-infected individuals: the drugs and the virusEffect of HCV Infection on Glucose Metabolism in Pregnant Women with HIV Receiving HAARTHow sweet it is? Susceptibility to diabetes mellitus in HIV-1 treatmentPrevalence and Pathogenesis of Diabetes Mellitus in HIV-1 Infection Treated With Combined Antiretroviral TherapyCohort profile: the Centers for AIDS Research Network of Integrated Clinical SystemsContribution of Metabolic and Anthropometric Abnormalities to Cardiovascular Disease Risk FactorsZidovudine/lamivudine contributes to insulin resistance within 3 months of starting combination antiretroviral therapyDrug-Induced Hyperglycemia and Diabetes MellitusDistribuição da gordura corporal e perfis lipídico e glicêmico de pacientes infectados pelo HIVUltrasonographic Measurement of Intra-Abdominal Fat Thickness in HIV-Infected Patients Treated or Not with Antiretroviral Drugs and Its Correlation to Lipid and Glycemic ProfilesGlucose metabolism, lipid, and body fat changes in antiretroviral-naive subjects randomized to nelfinavir or efavirenz plus dual nucleosidesDrug-induced diabetes mellitusGuidelines for the management of HIV infection in pregnan

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7326/0003-4819-127-10-199711150-00016

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Metadata

Authors
Visnegarwala, F., Krause, K. L., & Musher, D. M.
Venue
Annals of Internal Medicine
Published
1997-11-15
Volume
127
Issue
10
Pages
947
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2059654642
Cited by
136
References
0
FWCI
11.65
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Severe Diabetes Associated with Protease Inhibitor Therapy. https://app.cochat.ai/papers/10.7326/0003-4819-127-10-199711150-00016
The paper
Visnegarwala, F., Krause, K. L., & Musher, D. M. (1997). Severe Diabetes Associated with Protease Inhibitor Therapy. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-127-10-199711150-00016

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.